Research into fighting the flu, improving outcomes for vulnerable infants, and battling kidney disease has netted almost $42 million in funding for academics from The University of Queensland.
Sixty-one UQ projects were successful in the National Health and Medical Research Council (NHMRC) 2019 Project Grant funding announced today – the second-highest amount in Australia.
“UQ has a strong history of translating research into practical solutions that help solve global medical and health issues,” he said.
“For example, one of UQ’s previous recipients of NHMRC funding is Professor Ian Frazer, the co-inventor of a cervical cancer vaccine which has put Australia on track to become the first country to eradicate the disease by 2035.
“Immunotherapy expert Professor Ranjeny Thomas has also received NHMRC funding in the past, allowing her team to pursue innovative treatments for rheumatoid arthritis.
“I am sure that among the 61 projects funded this round there will be more medical breakthroughs that improve health around the world.”
In this round of funding, UQ received four grants of more than $1 million each.
The largest grant was awarded to Associate Professor Sunil Badve, Medicine, $1,748,533. Other grants were:
- Professor Andreas Schibler, Faculty of Medicine, received $1,600,099
- Professor Alpha Yap, Institute for Molecular Bioscience (IMB), received $1,111,250
- Associate Professor Benjamin Hogan, IMB, received $1,195,506
Several researchers also received two project grants each, proving the versatility of their work.
- Dr Kirsty Short, Faculty of Science
- Associate Professor Massimo Hilliard, Queensland Brain Institute (QBI)
- Associate Prof Benjamin Hogan, IMB
- A/Prof Bruno van Swinderen, QBI
- Dr Daniel Watterson, Faculty of Science
A full list of NHMRC Project Grant funding is here.